Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Virginia J Hoglund

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Circulation|December 8, 2011
Patterning the artery wall by lateral induction of Notch signalingVirginia J Hoglund, Mark W Majesky
Arteriosclerosis, Thrombosis, and Vascular Biology|September 17, 2010
Neointima formation: a local affairVirginia J Hoglund, Xiu Rong Dong, Mark W Majesky
Circulation Research|March 5, 2011
Parsing aortic aneurysms: more surprisesMark W Majesky, Xiu Rong Dong, Virginia J Hoglund
Circulation Research|February 5, 2011
Vascular smooth muscle progenitor cells: building and repairing blood vesselsMark W Majesky, Xiu Rong Dong, Jenna N Regan, et al.
Oncotarget|January 7, 2020
EGFR806-CAR T cells selectively target a tumor-restricted EGFR epitope in glioblastomaAli C Ravanpay, Juliane Gust, Adam J Johnson, et al.
Biorxiv : the Preprint Server for Biology|April 24, 2023
Carcinoma-associated fibroblast-like tumor cells remodel the Ewing sarcoma tumor microenvironmentEmma D Wrenn, April A Apfelbaum, Erin R Rudzinski, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Determining preclinical safety of Aclarubicin in pediatric malignanciesDarleen S Tu, Aaron K Olson, Kimberly S Waggie, et al.
Pediatric Blood & Cancer|November 27, 2025
Determining Preclinical Safety of Aclarubicin in Pediatric MalignanciesDarleen S Tu, Aaron K Olson, Kimberly S Waggie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2023
Cancer-Associated Fibroblast-Like Tumor Cells Remodel the Ewing Sarcoma Tumor MicroenvironmentEmma D Wrenn, April A Apfelbaum, Erin R Rudzinski, et al.
Journal for Immunotherapy of Cancer|October 29, 2020
Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responsesKatherine J Brempelis, Courtney M Cowan, Shannon A Kreuser, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Circulation|December 8, 2011
Patterning the artery wall by lateral induction of Notch signalingVirginia J Hoglund, Mark W Majesky
Arteriosclerosis, Thrombosis, and Vascular Biology|September 17, 2010
Neointima formation: a local affairVirginia J Hoglund, Xiu Rong Dong, Mark W Majesky
Circulation Research|March 5, 2011
Parsing aortic aneurysms: more surprisesMark W Majesky, Xiu Rong Dong, Virginia J Hoglund
Circulation Research|February 5, 2011
Vascular smooth muscle progenitor cells: building and repairing blood vesselsMark W Majesky, Xiu Rong Dong, Jenna N Regan, et al.
Oncotarget|January 7, 2020
EGFR806-CAR T cells selectively target a tumor-restricted EGFR epitope in glioblastomaAli C Ravanpay, Juliane Gust, Adam J Johnson, et al.
Biorxiv : the Preprint Server for Biology|April 24, 2023
Carcinoma-associated fibroblast-like tumor cells remodel the Ewing sarcoma tumor microenvironmentEmma D Wrenn, April A Apfelbaum, Erin R Rudzinski, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Determining preclinical safety of Aclarubicin in pediatric malignanciesDarleen S Tu, Aaron K Olson, Kimberly S Waggie, et al.
Pediatric Blood & Cancer|November 27, 2025
Determining Preclinical Safety of Aclarubicin in Pediatric MalignanciesDarleen S Tu, Aaron K Olson, Kimberly S Waggie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2023
Cancer-Associated Fibroblast-Like Tumor Cells Remodel the Ewing Sarcoma Tumor MicroenvironmentEmma D Wrenn, April A Apfelbaum, Erin R Rudzinski, et al.
Journal for Immunotherapy of Cancer|October 29, 2020
Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responsesKatherine J Brempelis, Courtney M Cowan, Shannon A Kreuser, et al.
Pageof 1